Dose adjustments for renal, hepatic, pediatric, obesity, and special populations
Calculate the loading dose to achieve target plasma concentration immediately
Calculate pediatric dose scaling using BSA, weight-based, and age-adjusted methods for Pediatric Study Plan (iPSP) dose justification and clinical trial design
Predict dose modifications for renal impairment studies per FDA/EMA guidance. Dettli method with CKD staging for special population sections
Child-Pugh classification and dose adjustment rationale for hepatic impairment clinical pharmacology studies and NDA submissions
Compare IBW, ABW, LBW, and BSA-based dosing strategies for weight-based dose selection in clinical development programs
Age-adjusted pharmacokinetic considerations and CrCl estimation for geriatric sub-population analysis in clinical pharmacology reviews
Predict drug-drug interaction magnitude from inhibition/induction parameters. FDA classification for DDI risk assessment and labeling recommendations
Calculate loading dose with current level accounting for first-in-human dose selection rationale and clinical trial protocol design
Predict drug removal during hemodialysis and supplemental dosing for renal impairment study design and product labeling
Correct phenytoin levels for low albumin and renal impairment using the Winter-Tozer equation